GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LAVA Therapeutics NV (FRA:4PKB) » Definitions » Total Long-Term Liabilities

LAVA Therapeutics NV (FRA:4PKB) Total Long-Term Liabilities : €32.38 Mil (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is LAVA Therapeutics NV Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. LAVA Therapeutics NV's Total Long-Term Liabilities for the quarter that ended in Mar. 2025 was €32.38 Mil.

LAVA Therapeutics NV Total Long-Term Liabilities Historical Data

The historical data trend for LAVA Therapeutics NV's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LAVA Therapeutics NV Total Long-Term Liabilities Chart

LAVA Therapeutics NV Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Long-Term Liabilities
Get a 7-Day Free Trial 4.55 8.53 33.45 32.48 33.50

LAVA Therapeutics NV Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.56 32.79 31.68 33.50 32.38

LAVA Therapeutics NV Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

LAVA Therapeutics NV Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of LAVA Therapeutics NV's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

LAVA Therapeutics NV Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LAVA Therapeutics NV (FRA:4PKB) » Definitions » Total Long-Term Liabilities
Comparable Companies
ALGS FGEN BOLD PPCB CYCC PLUR ANTX LTRN MLEC AAGH VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
LVTX:USA
Address
Yalelaan 62, Utrecht, UT, NLD, 3584 CM
Website
https://www.lavatherapeutics.com
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.

LAVA Therapeutics NV Headlines

No Headlines